Please enable JavaScript to continue using this application.

Compare $MDGL vs $TWST | Chartloom

Compare

$MDGL vs $TWST

Madrigal Pharmaceuticals Inc · Twist Bioscience Corp

MDGL

Madrigal Pharmaceuticals Inc

TWST

Twist Bioscience Corp

Compare $MDGL vs $TWST

Comparing Madrigal Pharmaceuticals Inc and Twist Bioscience Corp

MDGLMadrigal Pharmaceuticals Inc

TWSTTwist Bioscience Corp

MDGLMadrigal Pharmaceuticals Inc

Market cap

$10.88B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.94x

Rev growth (TTM)

149.0%

YTD performance

-20.6%

52W performance

8.0%

FCF yield

-1.9%

TWSTTwist Bioscience Corp

Market cap

$9.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.83x

Rev growth (TTM)

19.2%

YTD performance

393.3%

52W performance

387.3%

FCF yield

-1.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MDGL

TWST

Detailed metrics comparison

MDGL

Madrigal Pharmaceuticals Inc

TWST

Twist Bioscience Corp

Market Cap

MDGL$10.88B

TWST$9.95B

Enterprise Value

MDGL$10.93B

TWST$9.83B

Price

MDGL$471.75

TWST$159.78

P/E Ratio

MDGLN/A

TWSTN/A

P/S Ratio

MDGL8.47x

TWST23.04x

EV/Sales

MDGL8.51x

TWST22.77x

EV/EBITDA

MDGL699.23x

TWST0.00x

P/B Ratio

MDGL22.03x

TWST27.87x

P/FCF Ratio

MDGLN/A

TWSTN/A

EV/FCF

MDGL-52.02x

TWST-100.10x

PEG Ratio

MDGLN/A

TWSTN/A

Forward P/E (NTM)

MDGLN/A

TWSTN/A

Forward P/S (NTM)

MDGL5.94x

TWST18.83x

Revenue (TTM)

MDGL$1.28B

TWST$432M

Revenue Growth (YoY)

MDGL149.0%

TWST19.2%

Forward Rev Growth

MDGL41.6%

TWST15.0%

Gross Margin (TTM)

MDGL91.5%

TWST52.0%

Operating Margin (TTM)

MDGL0.0%

TWST0.0%

EBITDA Margin (TTM)

MDGL-25.0%

TWST-26.0%

Net Margin (TTM)

MDGL-25.3%

TWST-31.7%

FCF Margin (TTM)

MDGL-16.4%

TWST-22.7%

Net Income (TTM)

MDGL$-325M

TWST$-137M

FCF (TTM)

MDGL$-210M

TWST$-98M

EPS (TTM)

MDGL-$11.15

TWST-$2.19

ROE (TTM)

MDGL-5665.0%

TWST-2989.0%

ROA (TTM)

MDGL-2553.0%

TWST-2080.0%

ROIC (TTM)

MDGL-3556.0%

TWST-2989.0%

Cash

MDGL$293M

TWST$117M

Debt

MDGL$341M

TWST$0

Net Cash/Debt

MDGL$-48M

TWST$117M

Current Ratio (TTM)

MDGL3.20x

TWST2.67x

Quick Ratio (TTM)

MDGL2.76x

TWST2.30x

Debt/Equity (TTM)

MDGL0.65x

TWST0.00x

Debt/Assets (TTM)

MDGL0.0%

TWST0.0%

Interest Coverage (TTM)

MDGLN/A

TWSTN/A

Net Debt/EBITDA (TTM)

MDGL0.00x

TWST0.00x

Beta

MDGL-1.08

TWST2.17

52W Performance

MDGL8.0%

TWST387.3%

YTD Performance

MDGL-20.6%

TWST393.3%

% from 52W High

MDGL-23.3%

TWST-27.3%

% from 52W Low

MDGL19.9%

TWST585.8%

Asset Turnover (TTM)

MDGL1.01x

TWST0.66x

FCF Yield (TTM)

MDGL-1.9%

TWST-1.0%

Earnings Yield (TTM)

MDGL-3.0%

TWST-1.4%

Dividend Yield (TTM)

MDGLN/A

TWSTN/A

Rule of 40

MDGL132.7

TWST-3.6

EV/GP/RG

MDGL0.21

TWST1.94

Ticker research

View MDGL research View TWST research

Metric	MDGL Madrigal Pharmaceuticals Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.88B	$9.95B
Enterprise Value	$10.93B	$9.83B
Price	$471.75	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	8.47x	23.04x
EV/Sales	8.51x	22.77x
EV/EBITDA	699.23x	0.00x
P/B Ratio	22.03x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.02x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.94x	18.83x
Revenue & Growth
Revenue (TTM)	$1.28B	$432M
Revenue Growth (YoY)	149.0%	19.2%
Forward Rev Growth	41.6%	15.0%
Profitability
Gross Margin (TTM)	91.5%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-25.0%	-26.0%
Net Margin (TTM)	-25.3%	-31.7%
FCF Margin (TTM)	-16.4%	-22.7%
Net Income (TTM)	$-325M	$-137M
FCF (TTM)	$-210M	$-98M
EPS (TTM)	-$11.15	-$2.19
ROE (TTM)	-5665.0%	-2989.0%
ROA (TTM)	-2553.0%	-2080.0%
ROIC (TTM)	-3556.0%	-2989.0%
Financial Health
Cash	$293M	$117M
Debt	$341M	$0
Net Cash/Debt	$-48M	$117M
Current Ratio (TTM)	3.20x	2.67x
Quick Ratio (TTM)	2.76x	2.30x
Debt/Equity (TTM)	0.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.08	2.17
52W Performance	8.0%	387.3%
YTD Performance	-20.6%	393.3%
% from 52W High	-23.3%	-27.3%
% from 52W Low	19.9%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	1.01x	0.66x
FCF Yield (TTM)	-1.9%	-1.0%
Earnings Yield (TTM)	-3.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	132.7	-3.6
EV/GP/RG	0.21	1.94
Ticker research	View MDGL research	View TWST research

Valuation

P/S Ratio

MDGL

8.47x

TWST

23.04x

EV/FCF

TWST

-100.10x

MDGL

-52.02x

Growth & revenue

Revenue Growth TTM

MDGL

149.0%

TWST

19.2%

Forward Revenue Growth

MDGL

41.6%

TWST

15.0%

Profitability & performance

Gross Margin

MDGL

91.5%

TWST

52.0%

ROE

TWST

-2989.0%

MDGL

-5665.0%

FCF Yield %

TWST

-1.0%

MDGL

-1.9%

52-Week Performance

TWST

387.3%

MDGL

8.0%

Detailed metrics comparison

MDGL

Madrigal Pharmaceuticals Inc

TWST

Twist Bioscience Corp

Market Cap

MDGL$10.88B

TWST$9.95B

Enterprise Value

MDGL$10.93B

TWST$9.83B

Price

MDGL$471.75

TWST$159.78

P/E Ratio

MDGLN/A

TWSTN/A

P/S Ratio

MDGL8.47x

TWST23.04x

EV/Sales

MDGL8.51x

TWST22.77x

EV/EBITDA

MDGL699.23x

TWST0.00x

P/B Ratio

MDGL22.03x

TWST27.87x

P/FCF Ratio

MDGLN/A

TWSTN/A

EV/FCF

MDGL-52.02x

TWST-100.10x

PEG Ratio

MDGLN/A

TWSTN/A

Forward P/E (NTM)

MDGLN/A

TWSTN/A

Forward P/S (NTM)

MDGL5.94x

TWST18.83x

Revenue (TTM)

MDGL$1.28B

TWST$432M

Revenue Growth (YoY)

MDGL149.0%

TWST19.2%

Forward Rev Growth

MDGL41.6%

TWST15.0%

Gross Margin (TTM)

MDGL91.5%

TWST52.0%

Operating Margin (TTM)

MDGL0.0%

TWST0.0%

EBITDA Margin (TTM)

MDGL-25.0%

TWST-26.0%

Net Margin (TTM)

MDGL-25.3%

TWST-31.7%

FCF Margin (TTM)

MDGL-16.4%

TWST-22.7%

Net Income (TTM)

MDGL$-325M

TWST$-137M

FCF (TTM)

MDGL$-210M

TWST$-98M

EPS (TTM)

MDGL-$11.15

TWST-$2.19

ROE (TTM)

MDGL-5665.0%

TWST-2989.0%

ROA (TTM)

MDGL-2553.0%

TWST-2080.0%

ROIC (TTM)

MDGL-3556.0%

TWST-2989.0%

Cash

MDGL$293M

TWST$117M

Debt

MDGL$341M

TWST$0

Net Cash/Debt

MDGL$-48M

TWST$117M

Current Ratio (TTM)

MDGL3.20x

TWST2.67x

Quick Ratio (TTM)

MDGL2.76x

TWST2.30x

Debt/Equity (TTM)

MDGL0.65x

TWST0.00x

Debt/Assets (TTM)

MDGL0.0%

TWST0.0%

Interest Coverage (TTM)

MDGLN/A

TWSTN/A

Net Debt/EBITDA (TTM)

MDGL0.00x

TWST0.00x

Beta

MDGL-1.08

TWST2.17

52W Performance

MDGL8.0%

TWST387.3%

YTD Performance

MDGL-20.6%

TWST393.3%

% from 52W High

MDGL-23.3%

TWST-27.3%

% from 52W Low

MDGL19.9%

TWST585.8%

Asset Turnover (TTM)

MDGL1.01x

TWST0.66x

FCF Yield (TTM)

MDGL-1.9%

TWST-1.0%

Earnings Yield (TTM)

MDGL-3.0%

TWST-1.4%

Dividend Yield (TTM)

MDGLN/A

TWSTN/A

Rule of 40

MDGL132.7

TWST-3.6

EV/GP/RG

MDGL0.21

TWST1.94

Ticker research

View MDGL research View TWST research

Metric	MDGL Madrigal Pharmaceuticals Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$10.88B	$9.95B
Enterprise Value	$10.93B	$9.83B
Price	$471.75	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	8.47x	23.04x
EV/Sales	8.51x	22.77x
EV/EBITDA	699.23x	0.00x
P/B Ratio	22.03x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-52.02x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.94x	18.83x
Revenue & Growth
Revenue (TTM)	$1.28B	$432M
Revenue Growth (YoY)	149.0%	19.2%
Forward Rev Growth	41.6%	15.0%
Profitability
Gross Margin (TTM)	91.5%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-25.0%	-26.0%
Net Margin (TTM)	-25.3%	-31.7%
FCF Margin (TTM)	-16.4%	-22.7%
Net Income (TTM)	$-325M	$-137M
FCF (TTM)	$-210M	$-98M
EPS (TTM)	-$11.15	-$2.19
ROE (TTM)	-5665.0%	-2989.0%
ROA (TTM)	-2553.0%	-2080.0%
ROIC (TTM)	-3556.0%	-2989.0%
Financial Health
Cash	$293M	$117M
Debt	$341M	$0
Net Cash/Debt	$-48M	$117M
Current Ratio (TTM)	3.20x	2.67x
Quick Ratio (TTM)	2.76x	2.30x
Debt/Equity (TTM)	0.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.08	2.17
52W Performance	8.0%	387.3%
YTD Performance	-20.6%	393.3%
% from 52W High	-23.3%	-27.3%
% from 52W Low	19.9%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	1.01x	0.66x
FCF Yield (TTM)	-1.9%	-1.0%
Earnings Yield (TTM)	-3.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	132.7	-3.6
EV/GP/RG	0.21	1.94
Ticker research	View MDGL research	View TWST research